Medindia LOGIN REGISTER
Medindia
Advertisement

AMDL's Goodnak(R) Anti-Aging Skin Care Line Soon Available in Capsule & Lotion Form

Wednesday, June 25, 2008 General News
Advertisement
TUSTIN, Calif., June 24 AMDL, Inc. (Amex: ADL),(http://www.amdl.com), a leader in specialty pharmaceuticals, announced todayits subsidiary Jade Pharmaceutical, Inc. (JPI) anticipates releasing duringthe 3rd quarter of 2008 two new formulations of its popular Goodnak(R)anti-aging skin care product line. In addition to its high quality injectableformulation, JPI anticipates offering Goodnak in capsules and an easy-to-applylotion.
Advertisement

Based on general market information, the proposed pricing for these newformulations will be approximately US$40.00 per unit, with 60% gross profitmargins. JPI plans to sell both products through existing distributionchannels within the Henan, Sichuan, Guizhou, Shanxi, Xinjiang, Gansu, Hunnan,Zhejiang, Fujian, Liaoning and Heilongjiang Provinces of China. Together theseregions have a combined population of more than 376 million people. Inaddition to China, AMDL believes both products will be good candidates forexport to the North American and European markets.
Advertisement

According to Gary Dreher, CEO of AMDL, "With the popularity of the Goodnakbrand in China, combined with JPI's ability to sell through pre-approveddistribution channels, we anticipate sales to exceed well beyond our initialannual sales forecast for Goodnak of $24 million. This is extremely positivenews for the market, Company and our shareholders."

Additional information on AMDL, Goodnak and the Company's otherpharmaceutical products is available at http://www.amdl.com.

About AMDL:

AMDL, Inc. is a global specialty pharmaceutical Company. The Company isheadquartered in Tustin, California with operations in Shenzhen, Jiangxi, andJilin, China. Along with its subsidiary Jade Pharmaceutical Inc. (JPI), AMDLis devoted to the research, development, manufacture, and marketing ofdiagnostic, pharmaceutical, nutritional supplement, and cosmetic productscurrently in China. The Company employs approximately 320 people in the U.S.and China.

About Jade Pharmaceutical:

JPI has access to the fastest growing pharmaceutical and consumer marketin the world: China. AMDL, through its subsidiaries, Jade currentlymanufactures large volume injection fluids, tablets and other relatedproducts, holding licenses for 133 products. It also manufactures 107 generic,over the counter and supplemental pharmaceutical products under certifiedChinese Good Manufacturing Practice (CGMP) standards.

Forward-Looking Statements

This news release contains forward-looking statements within the meaningof the Private Securities Litigation Reform Act of 1995. Such statements aresubject to certain risks and uncertainties, and actual circumstances, eventsor results may differ materially from those projected in such forward-lookingstatements. The Company cautions readers not to place undue reliance on anyforward-looking statements. The Company does not undertake, and specificallydisclaims any obligation, to update or revise such statements to reflect newcircumstances or unanticipated events as they occur.

Contact: Kristine Szarkowitz206.310.5323 [email protected]

SOURCE AMDL, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close